David Cox Dies | GenomeWeb

David Cox Dies

David Cox, a senior vice president at Pfizer, has died, reports Matthew Herper at Forbes. Cox was 66. As Herper notes, Cox was part of the effort to sequence the human genome, then was the chief scientific officer of Perlegen before moving onto Pfizer where he oversaw genetic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Cancer Trial Halted

And, Poof, It's Gone

To Spot it Early

What About the Moon?

Just Easier This Way

Changes Ahead

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.